ScreenSteps VS Nutra Comp

Nutra Comp's answer:

Target companies: Dietary supplement brands, nutraceutical companies, contract manufacturers, and compliance consultancies — primarily US-market focused (FDA-regulated), ranging from small DTC brands launching their first SKU to established portfolio brands managing dozens of ingredients. Decision-makers: Brand owners/founders, regulatory affairs professionals, product development leads, compliance officers, marketing directors (at larger companies). Primary use case: Substantiating health claims on supplement labels and marketing materials with clinical evidence, in compliance with FDA DSHEA regulations.

Nutra Comp's answer:

Core problem: Substantiating supplement claims is brutally time-consuming and expensive. A single ingredient can take 40–100+ hours of manual PubMed research by a qualified compliance expert, costing thousands in consultant fees or staff time. Why alternatives fall short:

• Hiring compliance consultants costs $10,000–$50,000+ per ingredient and takes weeks to months
• Doing it manually in-house requires deep regulatory knowledge most brand teams don't have; results are inconsistent and slow
• Using generic AI tools (ChatGPT, etc.) produces unreliable, un-cited outputs that can't withstand regulatory scrutiny
• Ignoring substantiation exposes brands to FDA warning letters, FTC enforcement actions, and marketplace delistings What it costs them: Delayed product launches, compliance risk, expensive consultant fees, marketplace listing rejections, and potential legal liability. Emotional tension: Fear of FDA warning letters or FTC enforcement. Anxiety about whether claims will hold up under scrutiny. Frustration at how long and expensive the process is. Feeling overwhelmed by the volume of clinical literature.

Nutra Comp's answer:

Key differentiators:

• Automated PubMed search with intelligent filtering (healthy human subjects, oral administration, RCTs/meta-analyses/systematic reviews)
• AI-powered evidence extraction that distinguishes across-group vs. within-group significance — a critical regulatory distinction competitors ignore
• Structure–function claims generated in strict compliance with FDA Small Entity Compliance Guide; no disease claims, ever
• Confidence scoring system that ranks evidence strength, so brands know which claims are strongest
• Multi-platform compliance: claims flagged for FDA, Amazon Seller Central, and Google Merchant Center requirements
• Complete substantiation memo with sign-off metadata (brand, responsible person, compliance officer) — ready for internal review
• Professional PDF export formatted for sharing with legal, compliance, and regulatory teams How we do it differently: Deterministic data pipeline (PubMed search + XML parsing) combined with AI analysis. The LLM only handles summarisation and claim generation — never the raw data retrieval — eliminating hallucination risk for source citations. Why that's better: Every claim is traceable to real PubMed-indexed studies with verifiable PMIDs. No fabricated citations. No made-up p-values. Why customers choose us: Speed (minutes vs. months), cost savings (subscription vs. consultant retainers), consistency (same rigorous methodology every time), and confidence (every claim backed by verifiable clinical evidence).